Experience with methotrexate in a patient with calcium pyrophosphate crystal deposition disease

Современная ревматология

卷:13

E. V. Ilyinykh¹  M. S. Eliseev¹ 

[1] V.A. Nasonova Research Institute of Rheumatology;

关键词: pyrophosphate arthropathy;    calcium pyrophosphate crystal deposition disease;    chronic arthritis;    methotrexate;    colchicine;    hydroxychloroquine;    nonsteroidal anti-inflammatory drugs;   

DOI  :  10.14412/1996-7012-2019-4-96-98

来源: DOAJ

【 摘 要 】

The paper discusses the results of using methotrexate (MTX) in real clinical practice in a patient with calcium pyrophosphate crystal deposition resistant to traditional anti-inflammatory drugs (colchicine, nonsteroidal anti-inflammatory drugs, and hydroxychloroquine) It demonstrates the efficiency and possibility of safely using MTX at a dose of 20 mg/week during a year.

【 授权许可】

Unknown